What is Vivex?
Vivex operates as a pioneer in the field of regenerative medicine, focusing on the development of naturally sourced therapeutic solutions designed to enhance clinical and surgical patient outcomes. By utilizing the resources of the nation's oldest civilian tissue bank, the company addresses critical needs arising from trauma, injury, and chronic disease. Its core competency lies in harnessing the body's inherent healing mechanisms to provide medical professionals with advanced, innovative treatment options. As a key player in the biotech landscape, Vivex bridges the gap between traditional surgical intervention and biological restoration, positioning itself as a vital entity in modern healthcare infrastructure.
How much funding has Vivex raised?
Vivex has raised a total of $21.9M across 3 funding rounds:
Series A
$6.6M
Private Equity
$6.3M
Debt
$9M
Series A (2015): $6.6M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2017): $9M supported by Heritage Bank of Commerce
Key Investors in Vivex
Heritage Bank of Commerce
Founded in 1994 and headquartered in San Jose, California, Heritage Bank of Commerce is a bank that was created for business people and business banking.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Vivex?
With this major strategic investment, Vivex is well-positioned to scale its research and development initiatives, focusing on the commercialization of its proprietary tissue-based solutions. The company's transition from early-stage development to a more mature enterprise-level operation suggests a shift toward broader market penetration and the expansion of its clinical indications. Future growth will likely be driven by the integration of advanced biotechnological processes and the continued optimization of its supply chain, ensuring that its regenerative therapies remain accessible to a wider patient demographic. As the firm matures, stakeholders will be monitoring its ability to maintain regulatory compliance while scaling its innovative product pipeline to meet the rising global demand for advanced wound care and tissue repair technologies.
See full Vivex company page
